Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
STOK
#1932
Stoke Therapeutics, Inc. Common Stock
36.6
1
USD
+4.45%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+4.45%
Monthly Change
+9.09%
6 month change
+4.72%
Year Change
+391.41%
Previous Close
35.0
5
Open
36.3
0
Bid
Ask
Low
36.0
2
High
36.6
7
Volume
175
Markets
US Stock Market
Healthcare
STOK
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
54.08 M
54.6 M
54.8 M
57.12 M
59.15 M
—
Valuation ratios
Enterprise value
468.49 M
88.25 M
520.48 M
1.26 B
1.79 B
3.66 B
Price to earnings ratio
-6.68
8.11
12.9
33.57
-264.5
-209.92
Price to sales ratio
16.3
2.04
3.33
6.7
10.19
22.26
Price to cash flow ratio
-6.86
6.08
11.69
28.1
41.23
87.11
Price to book ratio
2.6
0.36
0.57
1.11
5.33
7.37
Enterprise value to EBITDA ratio
-4.72
2.19
12.31
43.28
-95.28
-37.5
Profitability ratios
Return on assets %
-0.04
0.28
-0.06
-0.11
-0.14
-0.03
Return on equity %
-0.05
0.32
-0.07
-0.12
-0.16
-0.04
Return on invested capital %
—
436.55
-103.01
-129.54
-185.11
18.89
Gross margin %
100
100
100
100
100
400
Operating margin %
-60.38
70.15
-197.58
-405.3
-4 382.24
-4 914.97
EBITDA margin %
-58.06
70.45
-194.35
-401.14
-4 353.35
-4 878.39
Net margin %
-46.35
71.19
-169.96
-360.68
-4 132.24
-4 591.69
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
5.81
8.41
6.98
6.53
5.28
27.2
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.08
0.47
0.03
0.03
0
0.53
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.43
2.22
-0.44
-0.52
-0.51
0.75
EBIT per share
-0.25
1.87
-0.47
-0.74
-1.04
-0.37
EBITDA per share
-0.24
1.88
-0.46
-0.73
-1.03
-0.34
Total debt per share
—
—
—
—
—
—
Cash per share
4.02
6.02
4.24
4.24
4.81
19.3
Net current asset value per share
4.31
6.33
4.63
4.65
5.16
20.76
Tangible book value per share
4.24
5.89
5.74
5.26
5.95
22.84
Working capital per share
3.57
5.57
3.96
3.94
4.18
17.66
Book value per share
4.24
5.89
5.74
5.26
5.95
22.84
News
Rocket Lab Soars, Leads 14 Onto Today's Premium Stock Screens
Orchestra BioMed Holdings, Inc. (OBIO) Surpasses Q4 Earnings and Revenue Estimates
Vertex (VRTX) Moves 8.3% Higher: Will This Strength Last?
Stoke Therapeutics stock hits 52-week high at 39.88 USD
Stoke Therapeutics earnings in focus amid Dravet trial progress
Dianthus Therapeutics, Inc. (DNTH) Stock Jumps 12.0%: Will It Continue to Soar?
We Told You So — These IBD 50 Stocks Dominate This Year
Natural Gas Giant Williams Leads 19 Stocks New To IBD Best Stock Lists
Stoke Therapeutics grants $697,125 bonus to CEO Ian F. Smith
Stoke Therapeutics stock hits 52-week high at 38.8 USD
These Growth Stocks Form Classic Cup Bases. Here's Where To Buy.
This Rare Disease Biotech Name Teases Around A Buy Point